Literature DB >> 15055485

Pulmonary functions in patients with type 2 diabetes mellitus & correlation with anthropometry & microvascular complications.

Sanjeev Sinha1, R Guleria, A Misra, R M Pandey, R Yadav, Sumit Tiwari.   

Abstract

BACKGROUND &
OBJECTIVES: The purpose of this study was to evaluate pulmonary functions including respiratory muscle strength in patients with type 2 diabetes mellitus (T2DM) and to determine their correlations with anthropometric profile, glycaemic control, and microangiopathic diabetic complications.
METHODS: Twenty nine patients with T2DM and 11 healthy control subjects were divided into the following three groups; (i) T2DM patients with any or a combination of microangiopathy(ies) (retinopathy, nephropathy, and peripheral neuropathy) (group 1, n=12); (ii) T2DM patients without any complications (group 2, n = 17); and (iii) a healthy control group (group 3, n=11). All patients were assessed with anthropometry, glycosylated haemoglobin (HbA1C), and lipid profile. Pulmonary functions were measured by spirometry. Pulmonary diffusion capacity for carbon monoxide (DLco) was measured by the steady state method. The presence of diabetic nephropathy was determined by 24 h protein excretion.
RESULTS: A significant reduction of DLco was observed in group 1 (P<0.001), as compared to the other groups. There were no differences among the three groups for other pulmonary functions; forced vital capacity, forced expired volume in one second, peak expiratory flow rate, and maximal static inspiratory and expiratory pressures. Significant correlations were observed between DLco and the following parameters in group 1; HbA1c (r=0.62, P<0.05), total cholesterol level (r = -0.44, P<0.05) and creatinine clearance (r=0.42, P<0.05). INTERPRETATION &amp;
CONCLUSION: The present study shows that the impairment of pulmonary diffusion capacity for carbon monoxide was common in T2DM Asian Indian patients having microangiopathy. Pathophysiologically, it could be related to glycaemic control or dyslipidaemia. Correlation of % BF with DLCo needs to be explored further.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15055485

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  10 in total

1.  Alveolar Gas Exchange and Pulmonary Functions in Patients with Type II Diabetes Mellitus.

Authors:  Anandhalakshmi S; Manikandan S; Ganeshkumar P; Ramachandran C
Journal:  J Clin Diagn Res       Date:  2013-08-28

2.  Assessment of lung function by spirometry and diffusion study and effect of glycemic control on pulmonary function in type 2 diabetes mellitus patients of the eastern India.

Authors:  Salim Uz-Zaman; Joyashree Banerjee; Anilbaran Singhamahapatra; Pranab Kumar Dey; Anindya Roy; Kaushik Roy; Kakali Roy Basu
Journal:  J Clin Diagn Res       Date:  2014-11-20

3.  Sex disparities in effects of cystic fibrosis-related diabetes on clinical outcomes: a matched study.

Authors:  R J Miller; H D Tildesley; P G Wilcox; H Zhang; S H Kreisman
Journal:  Can Respir J       Date:  2008-09       Impact factor: 2.409

4.  Pulmonary function tests in type 2 diabetes mellitus and their association with glycemic control and duration of the disease.

Authors:  Swati H Shah; Pranali Sonawane; Pradeep Nahar; Savita Vaidya; Sundeep Salvi
Journal:  Lung India       Date:  2013-04

5.  Pulmonary functions in patients with diabetes mellitus.

Authors:  Muhammad Irfan; Abdul Jabbar; Ahmed Suleman Haque; Safia Awan; Syed Fayyaz Hussain
Journal:  Lung India       Date:  2011-04

6.  Transfer factor for carbon monoxide in patients with COPD and diabetes: results from the German COSYCONET cohort.

Authors:  Kathrin Kahnert; Tanja Lucke; Frank Biertz; Andreas Lechner; Henrik Watz; Peter Alter; Robert Bals; Jürgen Behr; Rolf Holle; Rudolf M Huber; Stefan Karrasch; Beate Stubbe; Margarethe Wacker; Sandra Söhler; Emiel F M Wouters; Claus Vogelmeier; Rudolf A Jörres
Journal:  Respir Res       Date:  2017-01-13

7.  Pulmonary function tests in type 2 diabetes: a meta-analysis.

Authors:  Jesús Díez-Manglano; Uxua Asìn Samper
Journal:  ERJ Open Res       Date:  2021-02-01

8.  A Step Toward the Exploration of Better Spirometric Parameters for Early Diagnosis of Pulmonary Dysfunction in Persons With Type 2 Diabetes Mellitus.

Authors:  Rashmi R Dash; Bandita Panda; Madhuri Panigrahi; Biswaranjan Nayak
Journal:  Cureus       Date:  2022-07-06

9.  Early glycaemic variability increases 28-day mortality and prolongs intensive care unit stay in critically ill patients with pneumonia.

Authors:  Seong Ho Kim; Ji Young Kim; Eun Song Kim; Il Rae Park; Eun Yeong Ha; Seung Min Chung; Jun Sung Moon; Ji Sung Yoon; Kyu Chang Won; Hyoung Woo Lee
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

Review 10.  Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony.

Authors:  Aibek E Mirrakhimov
Journal:  Cardiovasc Diabetol       Date:  2012-10-27       Impact factor: 9.951

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.